Harmony Biosciences Quarterly Income Statements Chart
Quarterly
|
Annual
Harmony Biosciences Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| net product revenue | 200,489,000 | 184,733,000 | 201,267,000 | 186,038,000 | 172,814,000 | 154,615,000 | ||||||||||||||
| cost of product sold | 38,153,000 | 31,994,000 | 54,409,000 | 42,778,000 | 32,144,000 | 27,484,000 | 43,152,000 | 32,296,000 | 25,008,000 | 20,780,000 | 26,885,000 | 22,959,000 | 18,921,000 | 14,716,000 | 17,817,000 | 14,604,000 | 12,687,000 | 10,409,000 | 9,918,000 | 7,890,000 |
| gross profit | 162,336,000 | 152,739,000 | 146,858,000 | 143,260,000 | 140,670,000 | 127,131,000 | 125,260,000 | 127,972,000 | 109,208,000 | 98,346,000 | 101,423,000 | 94,247,000 | 88,107,000 | 70,597,000 | 73,396,000 | 66,128,000 | 61,134,000 | 49,265,000 | 46,370,000 | 37,719,000 |
| yoy | 15.40% | 20.14% | 17.24% | 11.95% | 28.81% | 29.27% | 23.50% | 35.78% | 23.95% | 39.31% | 38.19% | 42.52% | 44.12% | 43.30% | 58.28% | 75.32% | ||||
| qoq | 6.28% | 4.00% | 2.51% | 1.84% | 10.65% | 1.49% | -2.12% | 17.18% | 11.04% | -3.03% | 7.61% | 6.97% | 24.80% | -3.81% | 10.99% | 8.17% | 24.09% | 6.24% | 22.94% | |
| gross margin % | ||||||||||||||||||||
| operating expenses: | ||||||||||||||||||||
| research and development | 50,159,000 | 34,540,000 | 34,666,000 | 25,387,000 | 63,583,000 | 22,189,000 | 30,306,000 | 17,499,000 | 14,969,000 | 13,289,000 | 10,092,000 | 40,548,000 | 12,668,000 | 7,578,000 | 7,451,000 | 11,739,000 | 6,498,000 | 4,679,000 | 7,619,000 | 4,230,000 |
| sales and marketing | 30,073,000 | 30,711,000 | 27,600,000 | 27,576,000 | 28,507,000 | 27,233,000 | 26,886,000 | 23,418,000 | 24,528,000 | 22,572,000 | 21,075,000 | 20,467,000 | 20,160,000 | 17,583,000 | 19,109,000 | 16,480,000 | 17,022,000 | 15,506,000 | 17,527,000 | 12,601,000 |
| general and administrative | 33,924,000 | 31,243,000 | 28,865,000 | 28,587,000 | 27,224,000 | 25,676,000 | 27,872,000 | 22,546,000 | 22,809,000 | 22,062,000 | 22,643,000 | 21,331,000 | 22,163,000 | 17,880,000 | 18,205,000 | 16,856,000 | 14,302,000 | 14,547,000 | 13,466,000 | 10,508,000 |
| total operating expenses | 114,156,000 | 96,494,000 | 91,131,000 | 81,550,000 | 119,314,000 | 75,098,000 | 85,064,000 | 63,463,000 | 62,306,000 | 57,923,000 | 53,810,000 | 82,346,000 | 54,991,000 | 43,041,000 | 44,765,000 | 45,075,000 | 37,822,000 | 34,732,000 | 38,612,000 | 27,339,000 |
| operating income | 48,180,000 | 56,245,000 | 55,727,000 | 61,710,000 | 21,356,000 | 52,033,000 | 40,196,000 | 64,509,000 | 46,902,000 | 40,423,000 | 47,613,000 | 11,901,000 | 33,116,000 | 27,556,000 | 28,631,000 | 21,053,000 | 23,312,000 | 14,533,000 | 7,758,000 | 10,380,000 |
| yoy | 125.60% | 8.09% | 38.64% | -4.34% | -54.47% | 28.72% | -15.58% | 442.05% | 41.63% | 46.69% | 66.30% | -43.47% | 42.06% | 89.61% | 269.05% | 102.82% | ||||
| qoq | -14.34% | 0.93% | -9.70% | 188.96% | -58.96% | 29.45% | -37.69% | 37.54% | 16.03% | -15.10% | 300.08% | -64.06% | 20.18% | -3.75% | 35.99% | -9.69% | 60.41% | 87.33% | -25.26% | |
| operating margin % | ||||||||||||||||||||
| other income | -193,000 | -276,000 | 160,000 | -124,000 | 37,000 | -141,000 | 193,000 | -5,000 | -31,000 | 2,000 | 73,000 | 56,000 | 42,000 | -2,000 | 31,000 | 4,000 | -20,000 | -1,525,000 | ||
| interest expense | -3,646,000 | -3,836,000 | -4,209,000 | -4,348,000 | -4,404,000 | -4,535,000 | -15,430,000 | -2,906,000 | -2,776,000 | -2,645,000 | -3,583,000 | -3,990,000 | -3,927,000 | -4,169,000 | -4,187,000 | -5,429,000 | -7,227,000 | -7,127,000 | -7,966,000 | -6,946,000 |
| interest income | 5,296,000 | 5,044,000 | 4,477,000 | 4,932,000 | 4,705,000 | 4,428,000 | ||||||||||||||
| income before income taxes | 49,637,000 | 57,177,000 | 56,155,000 | 62,170,000 | 21,694,000 | 51,785,000 | 39,689,000 | 51,832,000 | 44,095,000 | 37,780,000 | 44,103,000 | 7,967,000 | 29,231,000 | 23,385,000 | 24,475,000 | -10,522,000 | 16,089,000 | 7,386,000 | -208,000 | 1,909,000 |
| income tax expense | -9,861,000 | -11,617,000 | -6,680,000 | -16,077,000 | -10,103,000 | -13,451,000 | -9,795,000 | -8,295,000 | -5,700,000 | -1,900,000 | ||||||||||
| net income | 39,776,000 | 45,560,000 | 49,475,000 | 46,093,000 | 11,591,000 | 38,334,000 | 26,607,000 | 38,461,000 | 34,300,000 | 29,485,000 | 48,509,000 | 87,943,000 | 23,531,000 | |||||||
| yoy | 243.16% | 18.85% | 85.95% | 19.84% | -66.21% | 30.01% | -45.15% | -56.27% | 45.77% | |||||||||||
| qoq | -12.70% | -7.91% | 7.34% | 297.66% | -69.76% | 44.07% | -30.82% | 12.13% | 16.33% | -39.22% | -44.84% | 273.73% | ||||||||
| net income margin % | ||||||||||||||||||||
| unrealized income on investments | -6,000 | 179,000 | -433,000 | 733,000 | -63,000 | -173,000 | 518,000 | 6,000 | ||||||||||||
| comprehensive income | 39,770,000 | 45,739,000 | 49,042,000 | 46,826,000 | 11,528,000 | 38,161,000 | 27,125,000 | 38,467,000 | 33,809,000 | 29,605,000 | 48,536,000 | 87,794,000 | 23,502,000 | |||||||
| earnings per share: | ||||||||||||||||||||
| basic | 0.69 | 0.79 | 0.87 | 0.81 | 0.2 | 0.68 | 0.46 | 0.64 | 0.57 | 0.49 | 0.82 | 1.48 | 0.4 | 0.36 | 0.39 | -0.17 | 0.25 | 0.13 | ||
| diluted | 0.68 | 0.78 | 0.85 | 0.79 | 0.2 | 0.67 | 0.45 | 0.63 | 0.56 | 0.48 | 0.79 | 1.44 | 0.39 | 0.35 | 0.38 | -0.17 | 0.24 | 0.13 | ||
| weighted-average number of shares of common stock - basic | 57,469,775 | 57,309,938 | 56,885,455 | 56,870,234 | 56,802,357 | 56,771,251 | 59,469,648 | 59,863,102 | 59,974,123 | 59,732,157 | 59,173,121 | 59,234,720 | 59,063,358 | 58,908,526 | 57,531,540 | 57,722,163 | 56,940,840 | 56,891,451 | 25,772,419 | 30,212,959 |
| weighted-average number of shares of common stock - diluted | 58,427,134 | 58,524,566 | 57,869,915 | 58,103,963 | 57,541,696 | 57,597,627 | 60,372,397 | 60,681,676 | 60,743,953 | 61,221,511 | 61,097,045 | 61,207,625 | 60,922,672 | 60,586,875 | 59,205,213 | 57,722,163 | 58,592,876 | 58,805,285 | 25,772,419 | 30,212,959 |
| loss on debt extinguishment | -9,766,000 | -26,146,000 | ||||||||||||||||||
| net product revenues | 103,402,500 | 160,268,000 | 134,216,000 | 119,126,000 | 128,308,000 | 117,206,000 | 107,028,000 | 85,313,000 | 91,213,000 | 80,732,000 | 73,821,000 | 59,674,000 | 56,288,000 | 45,609,000 | ||||||
| income tax benefit | -13,082,000 | -13,371,000 | 4,406,000 | 79,976,000 | -267,500 | 902,000 | ||||||||||||||
| unrealized loss on investments | -491,000 | 27,000 | -149,000 | -29,000 | ||||||||||||||||
| | ||||||||||||||||||||
| unrealized gain on investments | 120,000 | |||||||||||||||||||
| net income and comprehensive income | 21,485,000 | 22,714,000 | -9,620,000 | 14,117,000 | 7,386,000 | -9,184,000 | 1,909,000 | |||||||||||||
| accumulation of dividends on preferred stock | -6,013,000 | |||||||||||||||||||
| net income available to common stockholders | 22,714,000 | -9,620,000 | 14,117,000 | 7,386,000 | -208,000 | -4,104,000 | ||||||||||||||
| income taxes | -1,972,000 | |||||||||||||||||||
| net income per share | ||||||||||||||||||||
| basic | 1.67 | -0.14 | ||||||||||||||||||
| diluted | 1.67 | -0.14 |
We provide you with 20 years income statements for Harmony Biosciences stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Harmony Biosciences stock. Explore the full financial landscape of Harmony Biosciences stock with our expertly curated income statements.
The information provided in this report about Harmony Biosciences stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.